AU Patent

AU2009316874B2 — Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same

Assigned to Vertical Pharmaceuticals LLC · Expires 2016-06-16 · 10y expired

What this patent protects

Compositions and methods effective to minimize or eliminate the presence of oxidative degradation products in solid dosage forms comprising sufentanil are provided.

USPTO Abstract

Compositions and methods effective to minimize or eliminate the presence of oxidative degradation products in solid dosage forms comprising sufentanil are provided.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009316874B2
Jurisdiction
AU
Classification
—
Expires
2016-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Vertical Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.